Natalizumab induced cutaneous sarcoidosis-like reaction.


Journal

Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498

Informations de publication

Date de publication:
15 08 2019
Historique:
received: 21 03 2019
revised: 27 04 2019
accepted: 29 04 2019
pubmed: 21 5 2019
medline: 24 3 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

We present a case of a drug-induced sarcoidosis -like reaction (DISR) occurring following initiation of Natalizumab for multiple sclerosis. The reaction was purely cutaneous, and disappeared following drug withdrawal. We highlight this case to the practicing neurologists, with warning to be wary of a new rash on immunomodulatory therapies.

Identifiants

pubmed: 31108403
pii: S0165-5728(19)30136-5
doi: 10.1016/j.jneuroim.2019.04.015
pii:
doi:

Substances chimiques

Immunologic Factors 0
Natalizumab 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

476955

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

R Durcan (R)

Department of Neurology, Cork University Hospital, Ireland. Electronic address: Robert.durcan@hse.ie.

C Heffron (C)

Department of Histopathology, Cork University Hospital, Ireland.

B Sweeney (B)

Department of Neurology, Cork University Hospital, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH